Stilla Technologies
Business Services · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1 Mail Du Professeur Georges Mathé, Vill...Phone Number
+33 982295050Website
www.stillatechnologies.comRevenue
$14.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Stilla Technologies
Founded in 2013 and headquartered in Villejuif, Ile-de-France, France, Stilla Technologies is a biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing a flexible digital PCR (dPCR).Explore more
Stilla Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Stilla Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Stilla Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Stilla Technologies
Funding: Get notified immidiatlly once Stilla Technologies has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Stilla Technologies had a recent Job posting/layoffs
Check if Stilla Technologies has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Stilla Technologies recently announced quarterly report
Check out if Stilla Technologies is spiking on competitors!
Product Launch: Get notified when Stilla Technologies launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Stilla Technologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Stilla Technologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Stilla Technologies.
Stilla Technologies financials insights
Gather financial insights about Stilla Technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Angel/Seed
$135K
2018
Series A
$19.5M
2020
Series B
$22M
2021
Debt
$35M
Stilla Technologies Tech Stack
A closer look at the technologies used by Stilla Technologies
See more technologies
Most Recent Scoops
Open Position
Open Position
Hiring Plans
Stilla Technologies has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Areas of expertise include: Technical Leadership, Soft Lithography, Injection Molding, Risk Management, Business Ownership, Control Operation, and Lifecycle Management.
Hiring Plans
Open Position
Open Position
Stilla Technologies News & Media
Stilla Technologies adds 20 new oncology liquid biopsies kits to its reagents portfolio from partner ApexBio
BURLINGTON, Mass.--(BUSINESS WIRE)-- #PCR--Stilla Technologies today announced the availability of 20 new digital PCR assays, optimized for its Crystal Digital PCR™ platform, the naica® system, to be utilized for the detection of circulating tumor DNA (ctDNA) from liquid biopsy samples. Produced by distributor and technology partner ApexBio, these digital PCR kits are designed for the absolute quantitation of nucleic acids from genetic mutations found across a widespread range of oncological indStilla Technologies and Atila BioSystems to Co-Develop High-Plex Digital PCR Kits for Oncology
BOSTON--(BUSINESS WIRE)-- #PCR--Stilla Technologies and Atila BioSystems today announced an agreement to market digital PCR kits and assays produced by Atila BioSystems for use on the naica® system (Stilla Technologies). The digital PCR kits, optimized specifically for use with the 6-color naica® system, will be utilized for the detection of circulating tumor DNA (ctDNA) from liquid biopsy samples taken from patients with high-occurring cancer indications such as breast, lung, melanoma, prostateNew Stilla Ruby Chip and naica® system 21 CFR Part 11 compliance enable full automation of digital PCR testing for clinically-oriented applications
BOSTON--(BUSINESS WIRE)-- #PCR--Stilla Technologies, the multiplex digital PCR company, has recently introduced the Ruby Chip, the industry’s first ‘load-and-go’ consumable for digital PCR, optimized for its naica® system. The naica® system, which now supports 21 CFR Part 11 regulatory compliance, is part of a fully-automated sample-to-results workflow – the first of its kind for digital PCR. This platform serves the growing throughput and regulatory requirements of many clinically-oriented applStilla Technologies Solidifies Leadership in EMEA, Expands Footprint in APAC
PARIS & BOSTON--(BUSINESS WIRE)-- #PCR--Stilla Technologies, the multiplex digital PCR company, announces the addition of Yvan Sergeant to serve in the capacity of Vice President/General Manager for the EMEA region. Sergeant joins Stilla with over two decades of experience in the life sciences industry, scaling go-to-market teams and delivering substantial growth in both genomics and proteomics spaces. Yvan held prior leadership positions at PerkinElmer, Caliper Life Sciences, and Trinean, and c
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Stilla Technologies
Sign Up For FreeTo access detailed company insights
Founded in 2013 and headquartered in Villejuif, Ile-de-France, France, Stilla Technologies is a biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing a flexible digital PCR (dPCR).... Read More
